BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Phenobarbital
,
rs2300478
,
FGF21
,
glucose metabolic process
,
Arthritis
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Predicted Gene Targets for miR-103
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Dorsal root ganglia
Hippocampus
Cerebral cortex
Trigeminal ganglia
Occipital lobe
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Alpha-1-antitrypsin deficiency
Barrett's esophagus
Multiple-resistant Staphylococcus aureus infection
Vesicular stomatitis Indiana virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
JM 3100
GSK-1059615
CGP 60474
A 443654
everolimus
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR122
PPP2R2C
NOP2
NR5A1
IRF7
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
MicroRNA profiling of Multiple Sclerosis
microRNA expression data from pediatric primary intracranial germ cell tumors
MicroRNAs expressed in ATRA treated glioblastoma spheroid cultures
Human head and neck paraganglioma miRNA expression profiles
Nasopharyngeal carcinoma TW03 cell miRNA responses to Epstein-Barr viral LMP1 and LMP2A genes
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Predicted Gene Targets for miR-103
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomac…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ